SYNTHESIS OF ADRIAMYCIN SUGARS AND THIENAMYCIN
SYNTHESIS OF ADRIAMYCIN SUGARS AND THIENAMYCIN
批准号:
3171839
负责人:
M MARK MIDLAND
金额:
$2.88万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-02-01 至 1986-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Adriamycin, a member of the anthracycline family of antibiotics, has been
found to be highly effective against a wide variety of cancers.
Thienamycin is a Beta-lactam antibiotic isolated from streptomyces cattleya
that has shown unusually high potency against both gram-positive and
gram-negative bacteria. The chirality in these molecules plays a crucial
role in their biological activities. Hence the synthesis of the optically
active forms of these compounds is important. We have recently developed
two new methods for preparing optically-active molecules: asymmetric
reductions via trialkylboranes, and control of stereochemistry at the
migration terminus of organoborate rearrangements. The asymmetric
reduction of propargyl ketones makes essentially optically-pure propargyl
alcohols readily available, and the acetylene handle makes alcohols
attractive intermediates for further elaboration. The study of
organoborane rearrangements has made optically-active allylboranes readily
accessible for the first time. Addition of these organoboranes to a ketone
or aldehyde produces optically-active alcohols with several contiguous
chiral centers. These processes will be used in a novel lactone ring
expansion reaction that provides a series of closely related chiral
lactones that can be applied to both thienamycin and the sugar portion of
adriamycin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ASYMMETRIC REDUCTIONS VIA TRIALKYLBORANES
-
批准号:3272374
-
项目类别:
-
资助金额:$12.95万
-
财政年份:1978
-
负责人:M MARK MIDLAND
-
依托单位:
ASYMMETRIC REDUCTIONS VIA TRIALKYLBORANES
-
批准号:3272371
-
项目类别:
-
资助金额:$13.5万
-
财政年份:1978
-
负责人:M MARK MIDLAND
-
依托单位:
ASYMMETRIC REDUCTIONS VIA TRIALKYLBORANES
-
批准号:3272375
-
项目类别:
-
资助金额:$12.74万
-
财政年份:1978
-
负责人:M MARK MIDLAND
-
依托单位:
海外基金